my 12-62c has been researched along with pd-173952 in 1 studies
Studies (my 12-62c) | Trials (my 12-62c) | Recent Studies (post-2010) (my 12-62c) | Studies (pd-173952) | Trials (pd-173952) | Recent Studies (post-2010) (pd-173952) |
---|---|---|---|---|---|
41 | 0 | 31 | 9 | 0 | 6 |
Protein | Taxonomy | my 12-62c (IC50) | pd-173952 (IC50) |
---|---|---|---|
Glucose transporter | Leishmania mexicana | 5.492 | |
Hexose transporter 1 | Plasmodium falciparum (malaria parasite P. falciparum) | 4.496 | |
Platelet-derived growth factor receptor beta | Mus musculus (house mouse) | 0.64 | |
Tyrosine-protein kinase Lck | Homo sapiens (human) | 0.1506 | |
Platelet-derived growth factor receptor beta | Homo sapiens (human) | 0.2665 | |
Solute carrier family 2, facilitated glucose transporter member 1 | Homo sapiens (human) | 5.387 | |
Fibroblast growth factor receptor 1 | Homo sapiens (human) | 0.1883 | |
Proto-oncogene tyrosine-protein kinase Src | Homo sapiens (human) | 0.1681 | |
Platelet-derived growth factor receptor alpha | Homo sapiens (human) | 0.636 | |
D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 0.64 | |
Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase | Homo sapiens (human) | 0.0395 | |
calcium-dependent protein kinase 1 | Plasmodium falciparum 3D7 | 0.099 | |
protein kinase 6 | Plasmodium falciparum 3D7 | 0.145 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boesche, M; Crowther, GJ; Dasari, KS; Drewes, G; El Bakkouri, M; Fox, AM; Ghidelli-Disse, S; He, P; Hillesland, HK; Hui, R; Jones, JC; Keyloun, KR; Krahn, MM; Lafuente-Monasterio, MJ; Leonard, SE; Leroy, D; Maly, DJ; Mo, JS; Ojo, KK; Reid, MC; Rivas, KL; Van Voorhis, WC | 1 |
1 other study(ies) available for my 12-62c and pd-173952
Article | Year |
---|---|
Biochemical Screening of Five Protein Kinases from Plasmodium falciparum against 14,000 Cell-Active Compounds.
Topics: Antimalarials; Calcium; Cell Line, Tumor; Hep G2 Cells; Humans; Malaria, Falciparum; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase Kinases; Plasmodium falciparum; Protein Kinase Inhibitors; Protein Kinases; Protein Serine-Threonine Kinases; Protozoan Proteins | 2016 |